Related Experiment Video

Updated: Aug 8, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Treatment of infective endocarditis with recombinant tissue plasminogen activator

Adalet Meral Gunes1, Ozlem Mehtap Bostan, Birol Baytan

  • 1Department of Pediatric Hematology, Uludag University, Medical Faculty, Bursa, Turkey.

Pediatric Blood & Cancer
|May 23, 2006
PubMed

Insights

Infective endocarditis (IE) can be fatal if untreated. A novel approach using recombinant tissue plasminogen activator (r-tPA) successfully treated a pediatric patient with IE, offering a potential alternative to surgery.

Area of Science:

  • Cardiology
  • Hematology
  • Infectious Diseases

Background:

  • Infective endocarditis (IE) is a life-threatening microbial infection of the heart valves.
  • Standard treatment involves high-dose antibiotics, with surgery indicated for complications like embolic events or cardiac failure.
  • Surgery poses significant risks for critically ill pediatric patients.

Observation:

  • A 14-year-old male with Down syndrome and acute myeloblastic leukemia presented with IE.
  • The patient had large vegetations on the aortic and mitral valves.
  • Conventional treatment options were considered high-risk.

Findings:

  • The patient was successfully treated with recombinant tissue plasminogen activator (r-tPA).
  • This thrombolytic therapy provided an alternative to surgical intervention.
  • The treatment led to successful eradication of the infection and resolution of vegetations.

Implications:

  • Recombinant tissue plasminogen activator (r-tPA) may be a viable alternative treatment for pediatric IE, especially in high-risk surgical candidates.
  • This case highlights a potential new therapeutic strategy for complex IE cases in immunocompromised children.
  • Further research is warranted to establish the safety and efficacy of r-tPA in treating infective endocarditis.

More Related Videos

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...